Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.21K Buy
38
+15
+65% +$1.21K ﹤0.01% 424
2026
Q1
$1.63K Sell
23
-5
-18% -$374 ﹤0.01% 506
2025
Q4
$2.21K Buy
28
+5
+22% +$396 ﹤0.01% 457
2025
Q3
$1.9K Sell
23
-5
-18% -$393 ﹤0.01% 448
2025
Q2
$2.25K Hold
28
﹤0.01% 405
2025
Q1
$2.25K Buy
28
+5
+22% +$416 ﹤0.01% 382
2024
Q4
$1.88K Hold
23
﹤0.01% 383
2024
Q3
$1.9K Buy
23
+5
+28% +$374 ﹤0.01% 385
2024
Q2
$1.26K Hold
18
﹤0.01% 408
2024
Q1
$1.33K Buy
+18
New +$1.25K ﹤0.01% 379
2022
Q2
Sell
-104
Closed -$7K 517
2022
Q1
$7K Buy
+104
New +$7.03K ﹤0.01% 406
2018
Q3
Sell
-63
Closed -$3K 359
2018
Q2
$3K Buy
+63
New +$2.94K ﹤0.01% 319

Other funds holding MET

NVWM LLC's MET Position: Q2 2026 in Review

NVWM LLC increased its MetLife (MET) stake by 65% in Q2 2026, buying an estimated $1.21K and bringing the position to 38 shares worth $3.21K. The position accounts for ﹤0.01% of the portfolio, ranked #424.

NVWM LLC first reported a position in MET in Q2 2018 and has held it in 12 quarters since. The position peaked at $7K in Q1 2022. 1,440 funds tracked by Wall St. Rank hold MET as of Q2 2026.

  • NVWM LLC held 38 shares of MetLife worth $3.21K as of Q2 2026.
  • NVWM LLC bought 15 MetLife shares in Q2 2026, an estimated $1.21K.
  • MetLife made up ﹤0.01% of NVWM LLC's portfolio in Q2 2026, its #424 holding.
  • NVWM LLC first reported a position in MetLife in Q2 2018 and has held it in 12 quarters since.
  • NVWM LLC's MetLife position peaked at $7K in Q1 2022.
  • 1,440 funds tracked by Wall St. Rank held MetLife as of Q2 2026.

Based on NVWM LLC's 13F filing for Q2 2026, filed 29 Jul 2026.